Anixa Biosciences (ANIX) Share-based Compensation (IS) (2018 - 2026)
Anixa Biosciences' Share-based Compensation (IS) was $380,000 in fiscal Q3 2026 (quarter ended Jul 31, 2026), down 23.5% from $497,000 a year earlier but up 0.3% from the prior quarter.
Anixa Biosciences (ANIX) Share-based Compensation (IS) (2018 - 2026) Analysis & Trends
On a trailing twelve-month basis, Anixa Biosciences' Share-based Compensation (IS) was $3.21 million through Jul 31, 2026, up 12.9% year-over-year; for FY2025 (ended Oct 31, 2025), it came in at $3.68 million, down 16.7% from FY2024.
- Share-based Compensation (IS) shows a five-year compound annual growth rate of -1.3% (FY2020 to FY2025).
- In earlier fiscal years, Share-based Compensation (IS) was $4.42 million in FY2024 and $3.64 million in FY2022.
- Quarterly Share-based Compensation (IS) has moved between -$1.91 million (fiscal Q4 2022) and $2.35 million (fiscal Q1 2022) over five years.
- Compared with a year earlier, Share-based Compensation (IS) was higher in 1 of the last six quarters, with an average decline of 2.5%.
- The best year-over-year quarter for Share-based Compensation (IS) over five years was fiscal Q4 2025 (growth of 171.0%); the worst was fiscal Q3 2025 (a decline of 57.8%).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Anixa Biosciences | 101.33 Mn | 100.06 Mn | - | 380,000.00 |
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 380,000.00 |
| Apr 30, 2026 | 379,000.00 |
| Oct 31, 2025 | 1.95 Mn |
| Jul 31, 2025 | 497,000.00 |
| Apr 30, 2025 | 571,000.00 |
| Jan 31, 2025 | 1.06 Mn |
| Oct 31, 2024 | 721,000.00 |
| Jul 31, 2024 | 1.18 Mn |
| Apr 30, 2024 | 1.26 Mn |
| Jan 31, 2024 | 1.26 Mn |
| Jan 31, 2023 | 1.06 Mn |
| Oct 31, 2022 | -1.91 Mn |
| Jul 31, 2022 | 1.45 Mn |
| Apr 30, 2022 | 1.75 Mn |
| Jan 31, 2022 | 2.35 Mn |
| Oct 31, 2020 | 749,781.00 |
| Jul 31, 2020 | 1.04 Mn |
| Apr 30, 2020 | 1.11 Mn |
| Jan 31, 2020 | 1.02 Mn |
| Jul 31, 2019 | 830,898.00 |
Anixa Biosciences Share-based Compensation (IS) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=ANIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation-is", "ticker": "ANIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=ANIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();